Antiepileptic Medications in Development
- 1 September 1991
- journal article
- research article
- Published by SAGE Publications in DICP
- Vol. 25 (9), 978-986
- https://doi.org/10.1177/106002809102500913
Abstract
Recently, there has been an increase in the research devoted to the study of investigational antiepileptic medications. This has led to extensive clinical trials of several new compounds. This review focuses on four of these antiepileptic medications in development: felbamate, gabapentin, lamotrigine, and vigabatrin. Each has a unique mechanism of action and great potential for the treatment of epilepsy.Keywords
This publication has 34 references indexed in Scilit:
- Discontinuation of Phenytoin and Carbamazepine in Patients Receiving FelbamateEpilepsia, 1991
- Pharmacokinetics of Felbamate, a Novel Antiepileptic Drug: Application of Mixed‐Effect Modeling to Clinical TrialsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1989
- Effect of Felbamate on Phenytoin and Carbamazepine Serum ConcentrationsEpilepsia, 1989
- Mechanisms of Action of New Antiepileptic DrugsEpilepsia, 1989
- GABAergic mechanisms in the pathogenesis and treatment of epilepsy.British Journal of Clinical Pharmacology, 1989
- Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerationsEpilepsy Research, 1988
- A controlled study of progabide in partial seizuresNeurology, 1987
- Comparative Anticonvulsant Activity and Neurotoxicity of Felbamate and Four Prototype Antiepileptic Drugs in Mice and RatsEpilepsia, 1986
- Pharmacokinetics of W‐554 (ADD 03055) in Epileptic PatientsEpilepsia, 1985
- Antiepileptic Drug Development ProgramCleveland Clinic Journal of Medicine, 1984